Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,320) with videos related to
Page
of 132
Sort By:
Journal of the American College of Cardiology
|
August 7, 2013
The disconnect between the guidelines, the appropriate use criteria, and reimbursement coverage decisions: the ultimate dilemma
Richard I Fogel, Andrew E Epstein, N A Mark Estes, et al.
Pacing and Clinical Electrophysiology : PACE
|
April 1, 1995
NASPE/ACC/AHA/ESC medical/scientific statement special report--clinical investigation of antiarrhythmic devices: a statement for healthcare professionals from a Joint Task Force of the North American Society of Pacing and Electrophysiology, the American College of Cardiology, the American Heart Association, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology
S Saksena, A E Epstein, R Lazzara, et al.
Diabetes Care
|
September 18, 2008
C-Reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study
Barbara V Howard, Lyle Best, Anthony Comuzzie, et al.
Pacing and Clinical Electrophysiology : PACE
|
July 26, 2002
Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads
Robert G Hauser, David Cannom, David L Hayes, et al.
American Heart Journal
|
August 1, 1994
Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation
T J Lessmeier, M H Lehmann, R T Steinman, et al.
The American Journal of Cardiology
|
October 15, 1993
Outcome with implantable cardioverter-defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy or coronary artery disease without myocardial infarction
T J Lessmeier, M H Lehmann, R T Steinman, et al.
The American Journal of Cardiology
|
April 26, 2008
Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients
Raed A Aqel, Fadi G Hage, Gilbert J Zohgbi, et al.
Journal of Cardiovascular Electrophysiology
|
October 7, 2009
Idiopathic left ventricular arrhythmias originating adjacent to the left aortic sinus of valsalva: electrophysiological rationale for the surface electrocardiogram
Takumi Yamada, H Thomas McElderry, Taro Okada, et al.
The New England Journal of Medicine
|
October 19, 1989
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy
J E Parrillo, R E Cunnion, S E Epstein, et al.
Circulation
|
December 29, 2005
CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16
Eugenio Stabile, Timothy Kinnaird, Andrea la Sala, et al.
Page
of 132
Search research articles
Search
Showing results (1101-1110 of 1,320) with videos related to
Sort By:
Page
of 132
Journal of the American College of Cardiology
|
August 7, 2013
The disconnect between the guidelines, the appropriate use criteria, and reimbursement coverage decisions: the ultimate dilemma
Richard I Fogel, Andrew E Epstein, N A Mark Estes, et al.
Pacing and Clinical Electrophysiology : PACE
|
April 1, 1995
NASPE/ACC/AHA/ESC medical/scientific statement special report--clinical investigation of antiarrhythmic devices: a statement for healthcare professionals from a Joint Task Force of the North American Society of Pacing and Electrophysiology, the American College of Cardiology, the American Heart Association, and the Working Groups on Arrhythmias and Cardiac Pacing of the European Society of Cardiology
S Saksena, A E Epstein, R Lazzara, et al.
Diabetes Care
|
September 18, 2008
C-Reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study
Barbara V Howard, Lyle Best, Anthony Comuzzie, et al.
Pacing and Clinical Electrophysiology : PACE
|
July 26, 2002
Long-term structural failure of coaxial polyurethane implantable cardioverter defibrillator leads
Robert G Hauser, David Cannom, David L Hayes, et al.
American Heart Journal
|
August 1, 1994
Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation
T J Lessmeier, M H Lehmann, R T Steinman, et al.
The American Journal of Cardiology
|
October 15, 1993
Outcome with implantable cardioverter-defibrillator therapy for survivors of ventricular fibrillation secondary to idiopathic dilated cardiomyopathy or coronary artery disease without myocardial infarction
T J Lessmeier, M H Lehmann, R T Steinman, et al.
The American Journal of Cardiology
|
April 26, 2008
Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients
Raed A Aqel, Fadi G Hage, Gilbert J Zohgbi, et al.
Journal of Cardiovascular Electrophysiology
|
October 7, 2009
Idiopathic left ventricular arrhythmias originating adjacent to the left aortic sinus of valsalva: electrophysiological rationale for the surface electrocardiogram
Takumi Yamada, H Thomas McElderry, Taro Okada, et al.
The New England Journal of Medicine
|
October 19, 1989
A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy
J E Parrillo, R E Cunnion, S E Epstein, et al.
Circulation
|
December 29, 2005
CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16
Eugenio Stabile, Timothy Kinnaird, Andrea la Sala, et al.
Page
of 132